Bird & Bird LLP runs a series of seminars discussing various legal aspects of research and development.
Our third edition will deal with the new Belgian "innovation box deduction", which is set to replace the former patent box deduction. This new measure should allow for a 85% deduction computed on the net income stemming from qualifying IP.
The bill for this new legislation was introduced in Parliament on 21 December 2016 and was expected to be voted into law before year-end, but is currently still under consideration by Parliament - hopefully under urgency procedure. The law will be applicable retroactively as of 1 July 2016.
We will dive into the details of this legislation, including a specific focus on the IP and pharmaceutical regulatory aspects, considering that the new deduction will be much broader than patents, but also include plant variety rights, copyrighted software, orphan drug designations and other drugs and plant protection rights for which data and/or market exclusivity applies.
We will also take a look across the borders to see whether multi-jurisdictional enterprises have an interest in structuring their organization differently.
Would you like to attend?